Ritedose Now Offers the Largest Nebulized Drug Portfolio in the U.S.: FDA Approves the Company to Manufacture Generic Tobramycin Inhalation Solution

Ritedose receives FDA approval for Tobramycin Tobramycin expands nation's largest nebulized drug portfolio. - Generic ...
The Bakersfield Californian

Ritedose Now Offers the Largest Nebulized Drug Portfolio in the U.S.: FDA Approves the Company ...

Generic Tobramycin Inhalation Solution marks the first cystic fibrosis (CF) product in the Company’s portfolio ...
Mirage News

Research Reveals Aerosol Drug Use in ARDS Patients

A new review led by Associate Professor Sanjay Singhal from Dr. Ram Manohar Lohia Institute of Medical Sciences sheds light on the prevalence and ...

United States Nebulizer Market Research 2025-2033, Competitive Analysis of OMRON, GE Healthcare, Boston Scientific, Koninklijke Philips, Vectura, Aerogen, DeVilbiss Healthcare ...

The United States nebulizer market is set to grow from US$ 466.55 million in 2024 to US$ 730.62 million by 2033, with a CAGR of 5.11%. This growth is driven by the rising prevalence of respiratory ...